ImageneBio (IMA) Share-based Compensation (2020 - 2025)

ImageneBio has disclosed Share-based Compensation across 6 years of filings, most recently posting $14.0 million for Q3 2025.

• Share-based Compensation for Q3 2025 came in at $14.0 million, up 1274.43% year-over-year; the trailing twelve-month figure through Sep 2025 was $19.8 million (up 226.97% YoY), and the FY2024 annual result was $5.3 million, down 30.62% from the prior year.
• Share-based Compensation came in at $14.0 million for Q3 2025 at ImageneBio, up from $458000.0 in the prior quarter.
• In the past five years, Share-based Compensation ranged from a high of $14.0 million in Q3 2025 to a low of $57000.0 in Q1 2025.
• The 5-year median for Share-based Compensation is $1.8 million (2022), against an average of $2.3 million.
• Peak annual rise in Share-based Compensation reached 1274.43% in 2025, while the deepest fall reached 97.15% in 2025.
• ImageneBio's Share-based Compensation stood at $1.6 million in 2021, then climbed by 17.58% to $1.9 million in 2022, then retreated by 5.59% to $1.8 million in 2023, then surged by 201.71% to $5.3 million in 2024, then soared by 163.98% to $14.0 million in 2025.
• The last three Share-based Compensation figures came in at $14.0 million (Q3 2025), $458000.0 (Q2 2025), and $57000.0 (Q1 2025), per Business Quant data.